PT - JOURNAL ARTICLE AU - Noura Nachawi AU - Pratibha PR Rao AU - Vinni Makin TI - The role of GLP-1 receptor agonists in managing type 2 diabetes AID - 10.3949/ccjm.89a.21110 DP - 2022 Aug 01 TA - Cleveland Clinic Journal of Medicine PG - 457--464 VI - 89 IP - 8 4099 - http://www.ccjm.org/content/89/8/457.short 4100 - http://www.ccjm.org/content/89/8/457.full SO - Cleve Clin J Med2022 Aug 01; 89 AB - Glucagon-like peptide-1 (GLP-1) receptor agonists improve glycemic control in patients with type 2 diabetes mellitus, have cardioprotective and renoprotective effects, and do not cause weight gain or significant hypoglycemia. In fact, they have been found to be effective for weight loss in patients with obesity with and without diabetes. They are now the preferred drugs to add to the regimen when oral metformin by itself is not enough to meet the patient’s hemoglobin A1c goal.